Tributary Capital Management, LLC Insulet Corp Transaction History

Tributary Capital Management, LLC

$1.29 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$186.4 - $279.02 $876,080 - $1.31 Million	-4,700 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$194.8 - $275.7 $136,360 - $192,990	-700 Reduced 12.96%	4,700 $1.25 Million
Q4 2021 Jan 06, 2022	SELL	$255.32 - $318.29 $178,724 - $222,803	-700 Reduced 11.48%	5,400 $1.44 Million
Q1 2021 Apr 20, 2021	SELL	$235.95 - $293.05 $283,140 - $351,660	-1,200 Reduced 16.44%	6,100 $1.59 Million
Q4 2020 Jan 19, 2021	SELL	$215.97 - $265.89 $261,323 - $321,726	-1,210 Reduced 14.22%	7,300 $1.87 Million
Q3 2020 Oct 13, 2020	SELL	$192.55 - $236.59 $154,040 - $189,272	-800 Reduced 8.59%	8,510 $2.01 Million
Q2 2020 Jul 20, 2020	SELL	$159.17 - $224.73 $206,920 - $292,149	-1,300 Reduced 12.25%	9,310 $1.81 Million
Q1 2020 Apr 14, 2020	SELL	$130.01 - $216.44 $143,011 - $238,084	-1,100 Reduced 9.39%	10,610 $1.76 Million
Q4 2019 Jan 16, 2020	SELL	$144.81 - $186.0 $115,848 - $148,800	-800 Reduced 6.39%	11,710 $2.01 Million
Q1 2019 Apr 17, 2019	SELL	$72.44 - $101.87 $310,767 - $437,022	-4,290 Reduced 25.54%	12,510 $1.19 Million
Q4 2018 Jan 23, 2019	SELL	$73.27 - $105.19 $109,905 - $157,785	-1,500 Reduced 8.2%	16,800 $1.33 Million
Q3 2018 Oct 16, 2018	SELL	$81.43 - $108.13 $32,572 - $43,252	-400 Reduced 2.14%	18,300 $1.94 Million
Q2 2018 Jul 25, 2018	SELL	$83.27 - $101.93 $351,399 - $430,144	-4,220 Reduced 18.41%	18,700 $1.6 Million
Q4 2017 Jan 25, 2018	SELL	$55.67 - $71.8 $111,340 - $143,600	-2,000 Reduced 8.03%	22,920 $1.58 Million
Q3 2017 Oct 19, 2017	BUY	$49.68 - $59.46 $1.24 Million - $1.48 Million	24,920	24,920 $1.37 Million

Others Institutions Holding PODD

# of Institutions

687

Shares Held

62.6M

Call Options Held

640K

Put Options Held

881K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.

Account